Totem Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 21 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.37 M
as on 16-11-2024
- Satisfied Charges ₹ 2.50 M
as on 16-11-2024
- Revenue -39.62%
(FY 2023)
- Profit 7.75%
(FY 2023)
- Ebitda 2.53%
(FY 2023)
- Net Worth 7.37%
(FY 2023)
- Total Assets 11.32%
(FY 2023)
About Totem Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.37 M. The company has closed loans amounting to ₹2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Archna Jaiswal and Manohar Jaiswal serve as directors at the Company.
- CIN/LLPIN
U24231GJ2003PTC042042
- Company No.
042042
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Feb 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Totem Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archna Jaiswal  | Managing Director | 20-Feb-2003 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manohar Jaiswal | Whole-Time Director | 20-Feb-2003 | Current |
Financial Performance of Totem Biotech.
Totem Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 39.62% decrease. The company also saw a slight improvement in profitability, with a 7.75% increase in profit. The company's net worth moved up by a moderate rise of 7.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Totem Biotech?
In 2023, Totem Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aarpik Pharmaceuticals Private LimitedActive 29 years 11 monthsArchna Jaiswal and Manohar Jaiswal are mutual person
Aarpik Remedies Private LimitedActive 27 years 4 monthsArchna Jaiswal and Manohar Jaiswal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 01 Oct 2009 | ₹0.37 M | Open |
Bank Of India Creation Date: 26 Sep 2006 | ₹2.50 M | Satisfied |
How Many Employees Work at Totem Biotech?
Unlock and access historical data on people associated with Totem Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Totem Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Totem Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
